MYO3A: A Drug Target / Disease Biomarker (G53904)

Target Name: MYO3A

NCBI ID: G53904

MYO3A

MYO3A: A Drug Target / Disease Biomarker

Myo3A, a protein found in muscle cells, has been identified as a potential drug target or biomarker for several muscle-related conditions, including muscle weakness, muscle cramps, and muscle breakdown.

One of the reasons why Myo3A has potential as a drug target is its involvement in muscle protein synthesis and degradation. Myo3A plays a role in the regulation of muscle protein synthesis, which is the process by which the body builds and repairs muscle tissue. This is important for maintaining muscle mass and strength, as well as for maintaining overall physical function.

Additionally, Myo3A has been shown to be involved in the degradation of muscle protein, which is the process by which the body removes damaged or unnecessary protein from muscle tissue. This is important for maintaining muscle mass and strength, as well as for preventing muscle breakdown and other muscle-related conditions.

Another potential drug target for Myo3A is its role in muscle signaling. Myo3A has been shown to play a role in muscle signaling, which is the process by which the body communicates signals between muscle cells and other parts of the body. This is important for maintaining muscle function and for regulating muscle growth and development.

In addition to its role in muscle protein synthesis and degradation, Myo3A has also been shown to be involved in the regulation of muscle cell survival. This is important for maintaining muscle mass and strength, as well as for preventing muscle breakdown and other muscle-related conditions.

Overall, Myo3A is a protein that has the potential to be a drug target or biomarker for several muscle-related conditions. Further research is needed to fully understand its role in muscle biology and to develop effective treatments for these conditions.

Protein Name: Myosin IIIA

Functions: Probable actin-based motor with a protein kinase activity. Probably plays a role in vision and hearing (PubMed:12032315). Required for normal cochlear hair bundle development and hearing. Plays an important role in the early steps of cochlear hair bundle morphogenesis. Influences the number and lengths of stereocilia to be produced and limits the growth of microvilli within the forming auditory hair bundles thereby contributing to the architecture of the hair bundle, including its staircase pattern. Involved in the elongation of actin in stereocilia tips by transporting the actin regulatory factor ESPN to the plus ends of actin filaments (By similarity)

The "MYO3A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYO3A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets